PBLS NASDAQ
Parabilis Medicines, Inc.
1W: -3.0%
1M: -24.5%
3M: +3.7%
YTD: +51.4%
$30.28
-0.16 (-0.53%)
Weekly Expected Move ±11.9%
$23
$27
$30
$34
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.00
Neutral
1 bullish
0 neutral
1 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (52)
Parabilis Medicines (NASDAQ:PBLS) Stock Price Down 5.2% – Here’s Why
Parabilis Medicines (NASDAQ:PBLS) Shares Gap Up – Here’s What Happened
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
Market Movers | Winners: IVVD, PRTH, GRAL | Losers: EMAT, INDP, PBLS - Trefis
$PBLS stock is down 13% today. Here's what we see in our data. - quiverquant.com
Parabilis Medicines (NASDAQ:PBLS) Stock Price Down 6.3% - What's Next? - MarketBeat
Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to S&P TMI Index - marketscreener.com
Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Biotech Stocks At 52-Week Highs - MNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews
Biotech Stocks At 52-Week Highs - MNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - rttnews.com
Parabilis Medicines, Inc.(NasdaqGS:PBLS) added to Russell Small Cap Comp Growth Index - marketscreener.com
Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to Russell 3000 Value Benchmark - marketscreener.com
Parabilis Medicines (NASDAQ:PBLS) Hits New 52-Week High - Time to Buy? - MarketBeat
48,484 Shares in Parabilis Medicines, Inc. $PBLS Acquired by Squarepoint Ops LLC - MarketBeat
PBLS: Zolucatetide's clinical progress and platform innovation drive a broad pipeline and major upcoming milestones - TradingView
Parabilis Medicines (NASDAQ:PBLS) Trading Up 6% - Still a Buy? - MarketBeat
PBLS Price Today: Parabilis Medicines, Inc. Stock Price, Quote & Chart | MEXC - MEXC
WINTON GROUP Ltd Takes Position in Parabilis Medicines, Inc. $PBLS - MarketBeat
Parabilis Medicines (PBLS) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
1,920,805 Shares in Parabilis Medicines, Inc. $PBLS Purchased by Frazier Life Sciences Management L.P. - MarketBeat
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
Young startups miss out on biotech venture funding rebound, MassBio says
Parabilis Medicines (NASDAQ:PBLS) Hits New 12-Month High – What’s Next?
Parabilis Medicines: A Rare-Tumor Validation Ladder For An Undruggable Platform (NASDAQ:PBLS) - Seeking Alpha
Parabilis Medicines GAAP EPS of -$2.32, revenue of $0.15M
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Parabilis Medicines(PBLS.US) 10% Shareholder Buys US$6.92 Million in Common Stock - Moomoo
Parabilis Medicines, Inc.’s Quiet Period Will End Tomorrow (NASDAQ:PBLS)
Insider Stock Purchases: June 29, 2026 | PBLS Stock News - quiverquant.com
Insider Purchase: 10% owner at $PBLS Buys 375,000 Shares - quiverquant.com
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested
Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?
Parabilis Medicines (PBLS) Stock Forecast and Price Target 2026 - MarketBeat
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline
SpaceX Climbed Nearly 20% in Its First Day of Trading. Here's Where the Stock Price Will Be in 3 Months, According to History.
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline - Yahoo Finance
PBLS: Parabilis Medicines Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
How to Play PBLS Stock After the Parabilis IPO - Barchart.com
Parabilis Medicines, Inc. Common Stock (PBLS) Historical Quotes - nasdaq.com
PBLS - Finviz
Parabilis Medicines sets biotech record with $670m IPO - Yahoo Finance
Parabilis Medicines prices upsized IPO at $19 per share
Parabilis Medicines (PBLS) Stock Price, News & Analysis - Stock Titan
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
Parabilis upsizes IPO seeking to raise more than $600M
Parabilis IPO: 7 Things to Know Before PBLS’ $475M Debut - ebc.com
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN